AMNIS CORP
Profile
Company Names
AMNIS CORP
Addresses
2505 THIRD AVE., SUITE 210, SEATTLE, WA 98121
Phone Numbers
206-576-6850
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
WASHINGTON
Total Amount Raised:
$893,675.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2009-07-24
$893,675.00
$1,499,999.00
$606,324.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANNETTE
CAMPBELL-WHITE
DIRECTOR
CARL
GORDON
DIRECTOR
FARALLON BIOSCIENCES, INC
| AMNIS CORP
| IGENICA INC
| ACCELERON PHARMA INC
| ARAGON PHARMACEUTICALS, INC.
| GOOD START GENETICS, INC.
| ARSANIS, INC.
| SINGULEX INC
| SELECTA BIOSCIENCES INC
| IGENICA BIOTHERAPEUTICS, INC
| COMPASS THERAPEUTICS LLC
| ADICET BIO, INC.
| INTELLIA THERAPEUTICS, INC.
| ALECTOR LLC
| GEMINI THERAPEUTICS, INC.
| SPRINGWORKS THERAPEUTICS, LLC
| PREVAIL THERAPEUTICS INC.
| THESEUS PHARMACEUTICALS, INC.
| TP THERAPEUTICS, INC.
| KUMQUAT BIOSCIENCES INC
| PASSAGE BIO, INC.
| KEROS THERAPEUTICS, INC.
| ADARX PHARMACEUTICALS, INC.
| BLOSSOMHILL THERAPEUTICS, INC.
| SCRIBE THERAPEUTICS, INC.
| GARUDA THERAPEUTICS, INC.
| ODYSSEY THERAPEUTICS, INC.
| ALTEROME THERAPEUTICS, INC.
| AVENZO THERAPEUTICS, INC.
| MBX BIOSCIENCES, INC.
| ARRIVENT BIOPHARMA, INC.
| BELENOS BIOSCIENCES, INC.
| LOMOND THERAPEUTICS HOLDINGS, INC.
| STAR THERAPEUTICS LLC
DAVID
PERRY
EXECUTIVE OFFICER
AMNIS CORP
| GAIKAI INC.
| ANACOR PHARMACEUTICALS INC
| ANACOR PHARMACEUTICALS, INC.
| NUTRITION DEVELOPMENT GROUP, LLC
| HYDRAULEX INTERNATIONAL HOLDINGS, INC.
| FAREWELL LLC
| UROTRONIC, INC.
| CENTERCODE, INC.
| GOVYRL, INC.
| OPTILUME STRICTURE, LLC
| BETTER THERAPEUTICS, INC.
| HIGH RISE BEVERAGE COMPANY, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

